NEBIVOLOL: HAEMODYNAMIC EFFECTS AND CLINICAL SIGNIFICANCE OF COMBINED BETA-BLOCKADE AND NITRIC OXIDE RELEASE

NEBIVOLOL: HAEMODYNAMIC EFFECTS AND CLINICAL SIGNIFICANCE OF COMBINED BETA-BLOCKADE AND NITRIC OXIDE RELEASE

.

Bibliographic Details
Main Authors:	Otto Kamp, Marco Metra, Silvia Bugatti, Luca Bettari, Alessandra Dei Cas, Natalia Petrini, Livio Dei Cas
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1474

Similar Items

Current guidelines in the pharmacological management of chronic heart failure
by: Marco Metra, et al.
Published: (2004-03-01)

Current guidelines in the pharmacological management of chronic heart failure
by: Marco Metra, et al.
Published: (2004-03-01)

Possible genetic implications in the response to cardiac resynchronisation therapy in a patient affected by heart failure
by: Natalia Pezzali, et al.
Published: (2011-06-01)

Endocannabinoids and cardiovascular prevention: real progress?
by: Livio Dei Cas, et al.
Published: (2007-06-01)

Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade
by: Valerio Zacà, et al.
Published: (2009-02-01)

An era, a remembrance, a greeting…
by: Livio Dei Cas
Published: (2006-12-01)

Non-compaction of the ventricular myocardium
by: Livio Dei Cas, et al.
Published: (2006-12-01)

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
by: Livio Dei Cas, et al.
Published: (2009-08-01)

Raised homocystein plasma concentration in patients with Heart Failure: clinical significance
by: E. Vizzardi, et al.
Published: (2016-02-01)

Endothelial damage due to air pollution
by: Livio Dei Cas, et al.
Published: (2006-09-01)

Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation
by: Robert Weiss
Published: (2006-09-01)

Indemnización del daño moral en el derecho ambiental
by: Bárbara Dei-Cas
Published: (2009-12-01)

¿Es procedente la acción de nulidad contra las decisiones de las personas públicas no estatales relativas a conflictos individuales de trabajo?
by: Bárbara Dei-Cas
Published: (2010-07-01)

El concepto jurídico indeterminado como límite de la discrecionalidad
by: Bárbara Dei-Cas
Published: (2008-12-01)

Sudden death prevention in heart failure: The case of CIBIS III
by: Ronnie Willenheimer, et al.
Published: (2006-09-01)

Anemia and heart failure: a cause of progression or only a consequence?
by: Livio Dei Cas, et al.
Published: (2007-06-01)

Estudios sobre la responsabilidad de la administración. Carlos E. Delpiazzo, Universidad de Montevideo, 2009
by: Bárbara Dei – Cas Paiva
Published: (2009-06-01)

NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER
by: T. Műnzel, et al.
Published: (2016-01-01)

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
by: L.A. Fortepiani, et al.
Published: (2002-01-01)

Current bioethical issues in parasitology
by: Boury D., et al.
Published: (2008-09-01)

Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome
by: Guldem Mercanoglu, et al.
Published: (2019-11-01)

Foreword
by: Dei-Cas Eduardo, et al.
Published: (2008-09-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders
by: Valentina Spigoni, et al.
Published: (2022-10-01)

Metoprolol vs carvedilol in heart failure
by: Norton Michael, et al.
Published: (2000-10-01)

Effects on Nitric Oxide Production of Urolithins, Gut-Derived Ellagitannin Metabolites, in Human Aortic Endothelial Cells
by: Valentina Spigoni, et al.
Published: (2016-08-01)

Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.
by: Zheng Zhang, et al.
Published: (2014-01-01)

Intracranial bleeding mimicking an extensive acute myocardial infarction with reversible apical ballooning and systolic left ventricular dysfunction. A case report
by: Antonio D’Aloia, et al.
Published: (2016-02-01)

Beta-adrenoblockers in arterial hypertension treatment: focus on nebivolol
by: D. Voytsekhovsky, et al.
Published: (2008-08-01)

Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographics
by: Ben Ariff, et al.
Published: (2002-06-01)

Improved graft patency rates and mid-term outcome of diabetic patients undergoing total arterial myocardial revascularization
by: Livio Dei Cas, et al.
Published: (2006-12-01)

Nitric oxide mediated effects of nebivolol on erectile function in rats with heart failure
by: Guldem Mercanoglu, et al.
Published: (2021-07-01)

The role of nitric oxide in improving endothelial function andcardiovascular health: focus on nebivolol
by: G. L. Bakris, et al.
Published: (2011-04-01)

Beta-adrenoblocker nebivolol in the new Russian guidelines on arterial hypertension
by: L. G. Ratova, et al.
Published: (2008-08-01)

NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
by: Ni Putu Wirantari, et al.
Published: (2013-07-01)

Nebivolol other beta blockers in patients with hypertension and erectile dysfunction
by: Randall P. Sharp, et al.
Published: (2017-02-01)

β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure
by: G. Ambrosio, et al.
Published: (2011-08-01)

Anaemia and heart failure
by: Vizzardi Enrico, et al.
Published: (2011-02-01)

Prevalence of Cryptosporidium spp. (Eucoccidiorida: Cryptosporiidae) in seven species of farm animals in Tunisia
by: Soltane R., et al.
Published: (2007-12-01)

Cryptosporidium parvum (Eucoccidiorida: Cryptosporiidae) in calves: results of a longitudinal study in a dairy farm in Sfax, Tunisia
by: Soltane R., et al.
Published: (2007-12-01)